Post-operative radioactive iodine administration in patients with low-risk thyroid cancer

Nature Reviews Endocrinology, Published online: 20 June 2022; doi:10.1038/s41574-022-00709-zRadioactive iodine (RAI) treatment is used in patients with thyroid cancer to treat disease and to eradicate normal thyroid remnants. Routine post-operative administration of RAI is no longer indicated in patients with low risk thyroid cancer and might instead be used selectively in patients with a post-operative high serum level of thyroglobulin.
Source: Nature Reviews Endocrinology - Category: Endocrinology Authors: Source Type: research